Neoantigen Targeted Therapies Market Research Report by Target Disease Indication, by Neoantigens Type, by Immunotherapy Type, by Route of Administration - Global Forecast to 2025 - Cumulative Impact of COVID-19
Neoantigen Targeted Therapies Market Research Report by Target Disease Indication (Bone Cancer, Colorectal Cancer, Gynecological Cancer, Non-small Cell Lung Cancer, and Renal Cell Carcinoma), by Neoantigens Type (Off-the-shelf Neoantigens and Personalized Neoantigens), by Immunotherapy Type, by Route of Administration - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neoantigen Targeted Therapies Market is expected to grow from USD 1,255.15 Million in 2020 to USD 6,166.54 Million by the end of 2025. 2. The Global Neoantigen Targeted Therapies Market is expected to grow from EUR 1,100.54 Million in 2020 to EUR 5,406.94 Million by the end of 2025. 3. The Global Neoantigen Targeted Therapies Market is expected to grow from GBP 978.38 Million in 2020 to GBP 4,806.78 Million by the end of 2025. 4. The Global Neoantigen Targeted Therapies Market is expected to grow from JPY 133,956.66 Million in 2020 to JPY 658,126.74 Million by the end of 2025. 5. The Global Neoantigen Targeted Therapies Market is expected to grow from AUD 1,822.64 Million in 2020 to AUD 8,954.64 Million by the end of 2025.
Market Segmentation & Coverage: This research report categorizes the Neoantigen Targeted Therapies to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Target Disease Indication, the Neoantigen Targeted Therapies Market studied across Bone Cancer, Colorectal Cancer, Gynecological Cancer, Non-small Cell Lung Cancer, and Renal Cell Carcinoma.
Based on Neoantigens Type, the Neoantigen Targeted Therapies Market studied across Off-the-shelf Neoantigens and Personalized Neoantigens.
Based on Immunotherapy Type, the Neoantigen Targeted Therapies Market studied across DNA / RNA-based Vaccines, Dendritic Cell Vaccines, Protein / Peptide-based Vaccines, and TIL-based Therapies.
Based on Route of Administration, the Neoantigen Targeted Therapies Market studied across Intradermal, Intravenous, and Subcutaneous.
Based on Geography, the Neoantigen Targeted Therapies Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neoantigen Targeted Therapies Market including Aduro Biotech, Inc., Bavarian Nordic, Caladrius Biosciences, Genocea Biosciences, Gradalis, Immunicum, Immunovative Therapies, Iovance Biotherapeutics, Medigene, Neon Therapeutics, Precision Biologics, and Vaxon Biotech.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch™ FPNV Positioning Matrix: The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Neoantigen Targeted Therapies Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch™ Competitive Strategic Window: The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Neoantigen Targeted Therapies Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neoantigen Targeted Therapies Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neoantigen Targeted Therapies Market? 4. What is the competitive strategic window for opportunities in the Global Neoantigen Targeted Therapies Market? 5. What are the technology trends and regulatory frameworks in the Global Neoantigen Targeted Therapies Market? 6. What are the modes and strategic moves considered suitable for entering the Global Neoantigen Targeted Therapies Market?
Our reports have been used by over 10K customers, including:
Gliosarcoma - Pipeline Review, H2 2020
latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Pipeline Review, H2 2020, provides an overview of the Gliosarcoma (Oncology) pipeline landscape.
Gliosarcoma is a type of brain tumor that originates from glial cells....
915 pages •
By Global Industry Analysts
• Sep 2020
The global market for Cancer Therapies is projected to reach US$220.5 billion by 2025, driven by the rise in cancer prevalence to epidemic proportions and the still ongoing search to find effective treatments for the disease. Despite decades of research costing billions of dollars, a cure for cancer still remains elusive. This fact when juxtaposed...
The oncology information systems market is projected to reach USD 9.5 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 7.4% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of cancer cases, and growing public and private investments, funding, and grants...
Bone Cancer Treatment Market Report Overview Bone Cancer Treatment market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Bone Cancer Treatment market types and applications. It is a focused study on Bone Cancer Treatment market space including...
Urothelial Cancer Drugs Market Report Overview Urothelial Cancer Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Urothelial Cancer Drugs market types and applications. It is a focused study on Urothelial Cancer Drugs market space...
126 pages •
By Global Industry Analysts
• Mar 2021
- StrategyR - A Trademark of Global Industry Analysts, Inc.
- Project Edition: 8
- Influencer Pool: 1249
- MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....